The Food and Drug Administration would be making an unusual move if it greenlights Johnson & Johnson's experimental depression treatment, according to a briefing...

Better-than-expected positive results from a late-stage study could position Merck & Co's immunotherapy Keytruda to play a large role in the treatment of metasta...

A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple s...

First presentation of data from the pivotal Phase III ARAMIS trial with the investigational compound darolutamide in patients with advanced prostate cancer that has ...

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference Plymouth Meetin...

Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is a chronic neurodegener...